Pfizer Fails To Get Geodon Off-Label Use Case Tossed
A Massachusetts federal judge on Wednesday refused to throw out a False Claims Act whistleblower suit alleging Pfizer Inc. improperly promoted off-label use of schizophrenia drug Geodon, instead trimming the suit...To view the full article, register now.
Already a subscriber? Click here to view full article